.

Regulus Therapeutics reported $4.45M in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
AstraZeneca AZN:LN 2425311.81M 57309.55M
Astrazeneca AZN:US $ 29528M 1571M
Biogen BIIB:US $ 7277.2M 2M
Celldex Therapeutics CLDX:US $ 0M 0M
GlaxoSmithKline GSK:LN 2211100M 1121700M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Intrexon XON:US $ 198.67M 2.79M
IONIS PHARMACEUT IONS:US $ 1253.13M 1M
Lexicon Pharmaceuticals LXRX:US $ 23.63M 154K
Ligand Pharmaceuticals LGND:US $ 115.02M 61.57M
Omeros OMER:US $ 314.36M 454K
Regulus Therapeutics RGLS:US $ 4.45M 0.03M
Sangamo Biosciences SGMO:US $ 0M 0M
Takeda 4502:JP Y 4602254M 256843M
Vital Therapies VTL:US $ 0M 0M
YTE INCY:US $ 34.19M 0.01M